Adial(ADIL)03-28 06:15
$Adial(ADIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-026708 Size: 5 KB 网页链接查看全文
Adial(ADIL)03-28 06:15
$Adial(ADIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-026712 Size: 5 KB 网页链接查看全文
Adial(ADIL)03-28 06:15
$Adial(ADIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-026706 Size: 5 KB 网页链接查看全文
Adial(ADIL)03-28 06:25
$Adial(ADIL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-026724 Size: 5 KB 网页链接查看全文
Adial(ADIL)04-02 04:05
$Adial(ADIL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-24-028701 Act: 34 Size: 6 MB 网页链接查看全文
Adial(ADIL)03-15 05:15
$Adial(ADIL)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001213900-24-022663 Act: 33 Size: 13 KB 网页链接查看全文
智通财经APP获悉,6月22日(周二),生物制药公司Adial Pharmaceuticals(ADIL.US)股价走高,截至北京时间22:26,该股涨超15%,报3.318美元。此前有分析指出,欧洲药品管理局(EMA)或将批准其治疗酒精使用障碍药物,这有望成为刺激该股股价... 网页链接
生物制药公司Adial Pharmaceuticals(ADIL.O)涨超19%,此前有报道称,EMA将批准其酒精使用障碍药物。 网页链接
智通财经APP获悉,6月22日(周二)美股开盘,三大指数齐涨,道琼斯指数涨0.03%,报33886.28点;标普500指数涨0.05%,报4226.78点;纳斯达克综合指数涨0.03%,报14145.52点。 个股消息 生物制药公司Adial Pharmaceuticals(ADIL.US)涨23.52%,... 网页链接
$Adial制药(ADIL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-23-039032 Act: 34 Size: 288 KB 网页链接
$Adial制药(ADIL)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-23-038985 Act: 34 Size: 3 MB 网页链接
$Adial制药(ADIL)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001213900-23-038128 Act: 34 Size: 300 KB 网页链接
$Adial制药(ADIL)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001213900-23-029521 Act: 34 Size: 256 KB 网页链接
$Adial制药(ADIL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-23-024937 Act: 34 Size: 283 KB 网页链接
$Adial制药(ADIL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001213900-23-024719 Act: 34 Size: 7 MB 网页链接
$Adial制药(ADIL)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-23-023830 Act: 34 Size: 78 KB 网页链接
$Adial制药(ADIL)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001213900-23-021587 Act: 34 Size: 366 KB 网页链接
$Adial制药(ADIL)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001213900-23-018221 Act: 34 Size: 3 MB 网页链接
$Adial制药(ADIL)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-23-017857 Act: 34 Size: 2 MB 网页链接